APA

Rubenstein J. L., Geng H., Fraser E. J., Formaker P., Chen L., Sharma J., Killea P., Choi K., Ventura J., Kurhanewicz J., Lowell C., Hwang J., Treseler P., Sneed P. K., Li J., Wang X., Chen N., Gangoiti J., Munster P. N. & Damato B. (20190403). Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. : Blood advances.

Chicago

Rubenstein James L, Geng Huimin, Fraser Eleanor J, Formaker Paul, Chen Lingjing, Sharma Jigyasa, Killea Phoebe, Choi Kaylee, Ventura Jenny, Kurhanewicz John, Lowell Clifford, Hwang Jimmy, Treseler Patrick, Sneed Penny K, Li Jing, Wang Xiaomin, Chen Nianhang, Gangoiti Jon, Munster Pamela N and Damato Bertil. 20190403. Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. : Blood advances.

Harvard

Rubenstein J. L., Geng H., Fraser E. J., Formaker P., Chen L., Sharma J., Killea P., Choi K., Ventura J., Kurhanewicz J., Lowell C., Hwang J., Treseler P., Sneed P. K., Li J., Wang X., Chen N., Gangoiti J., Munster P. N. and Damato B. (20190403). Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. : Blood advances.

MLA

Rubenstein James L, Geng Huimin, Fraser Eleanor J, Formaker Paul, Chen Lingjing, Sharma Jigyasa, Killea Phoebe, Choi Kaylee, Ventura Jenny, Kurhanewicz John, Lowell Clifford, Hwang Jimmy, Treseler Patrick, Sneed Penny K, Li Jing, Wang Xiaomin, Chen Nianhang, Gangoiti Jon, Munster Pamela N and Damato Bertil. Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. : Blood advances. 20190403.